About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,781 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,781 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 361-380 of 4,781 trials

TerminatedTo Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal AdenocarcinomasA dose escalation trial to assess the safety of plerixafor in patients with advanced pancreatic, high grade serous ovarian and colorectal cancer.NCT03277209·New York, New York and 1 other RecruitingProfiling Program of Advanced/Metastatic Pancreatic Cancer PatientsThe proposal is to implement a molecular screening program for advanced/metastatic pancreatic cancer patients before the initiation of 1st line treatment in order to allow a…NCT05380414·Lyon CompletedA Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsThis is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily…NCT02009449·Los Angeles, California and 9 others

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

Not yet recruitingA Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced Pancreatic CancerPain from advanced pancreatic cancer is often difficult to control. This pain commonly occurs when the cancer affects a network of nerves in the abdomen called the coeliac plexus.NCT07689955

TerminatedGene Expression in Pancreatic CancerPancreatic cancer is a lethal disease. The 1-year and 5-year survival rate is approximately 20% and \<5% respectively.NCT03531125·Oxford

CompletedContinuous Monitoring on the General WardRationale: Monitoring patients' vital signs is done to detect clinical deterioration.NCT02933307

UnknownStudy of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the PancreasA randomized multi-center phase II trial of nab-paclitaxel in combination with gemcitabine verus S1 with gemcitabine as first-Line treatment for locally advanced or metastatic…NCT03779464·Wuhan, Hubei

UnknownA Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismThis is an open label, multi-center, and randomized phase II trial designed to compare the safety and efficacy of direct oral anticoagulants and subcutaneous dalteparin in…NCT03139487·Seoul

CompletedA Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)Open-label, phase I, non-randomized, multicentric study of single-agent birabresib (MK-8628) (formerly known as OTX015) administered according to two distinct regimens to…NCT02259114

TerminatedGemcitabine and CT-011 for Resected Pancreatic CancerBackground: * In 2009, 49,096 patients were diagnosed with pancreatic cancer. Pancreatic cancer carries a poor prognosis with an overall 5-year relative survival rate of 5.6%.NCT01313416·Augusta, Georgia

CompletedBevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic CancerThis randomized phase II trial is studying bevacizumab, gemcitabine, and cetuximab to see how well they work compared to bevacizumab, gemcitabine, and erlotinib in treating…NCT00091026·Chicago, Illinois

CompletedCPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerThis pilot clinical trial studies 6,8-bis(benzylthio)octanoic acid in treating patients with locally advanced or metastatic pancreatic cancer.NCT01839981·Winston-Salem, North Carolina

Active not recruitingDOTATOC PET/CT for Imaging NET PatientsNeuroendocrine tumours (NETs) are generally slow growing, but some can be aggressive and resistant to treatment.NCT03583528·Vancouver, British Columbia

UnknownI125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic CancerData of 100 patients with locally advanced pancreatic cancer who received stereotactic radiotherapy or ct-guided radioactive 125I seed implantation in the multicenter of the…NCT03964064·Beijing, Beijing Municipality and 3 others

UnknownSurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic LesionsThe SurePathTM has been approved by the FDA since 1997.NCT03606148·Seoul

RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 132 others

CompletedAntiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)The purpose of this study is to evaluate the safety, and tolerability of HLA-A\*2402 restricted epitope peptide VEGFR1 and VEGFR2 emulsified with Montanide ISA 51 in combination…NCT00655785·Fukushima, Fukushima

RecruitingA Study of Blood Based Biomarkers for Pancreas AdenocarcinomaThe purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.NCT03334708·Middletown, New Jersey and 12 others

CompletedDiet and Exercise After Pancreatic CancerDetermine feasibility of a randomized controlled trial (RCT) in pancreatic (\& other foregut) cancer patients comparing the effects of diet alone vs. diet+exercise on functional…NCT03187028·Birmingham, Alabama

CompletedAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsWe are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research.NCT01931644·Los Angeles, California

PreviousPage 19 of 240Next